Cours suspendu

Communiqués IGM Biosciences, Inc.

Actions

IGMS

US4495851085

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 13/08/2025			Varia. 5j.	Varia. 1 janv.
1,270 ^USD	-2,31%		-.--%	-

14/08/25	IGM Biosciences, Inc. annonce la démission de plusieurs membres de son conseil d'administration	CI
14/08/25	Concentra Biosciences finalise l'acquisition d'IGM Biosciences pour 76,3 millions de dollars	CI

Communiqués

01/07/25	IGM Biosciences Enters into Agreement to Be Acquired by Concentra Biosciences for $1.247 in Cash per Share Plus a Contingent Value Right	GL
09/01/25	IGM Biosciences Provides Strategic Update on Autoimmunity Pipeline Programs	GL
09/01/25	IGM Biosciences Provides Strategic Update on Autoimmunity Pipeline Programs	AQ
08/11/24	IGM Biosciences : Announces Third Quarter 2024 Financial Results and Provides Corporate Update Form 8 K	PU
08/11/24	IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update	GL
04/11/24	IGM Biosciences to Present at Three Upcoming Investor Conferences	AQ
04/11/24	IGM Biosciences to Present at Three Upcoming Investor Conferences	GL
03/10/24	IGM Biosciences : Announces Strategic Pivot to Focus Exclusively on Autoimmunity Form 8 K	PU
30/09/24	IGM Biosciences Announces Strategic Pivot to Focus Exclusively on Autoimmunity	AQ
30/09/24	IGM Biosciences Announces Strategic Pivot to Focus Exclusively on Autoimmunity	GL
10/09/24	IGM Biosciences to Present at the Stifel 2024 Virtual Immunology and Inflammation Summit	GL
14/08/24	IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate Update	GL
05/07/24	IGM Biosciences : Regulation FD Disclosure Form 8 K	PU
29/05/24	IGM Biosciences to Present at the Jefferies Healthcare Conference	GL
08/05/24	IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update	GL
07/05/24	IGM Biosciences to Present at the 2024 RBCCM Global Healthcare Conference	GL
17/04/24	IGM Biosciences Announces Refocusing of Sanofi Collaboration	GL
10/04/24	IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum	GL
07/03/24	IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	AQ
07/03/24	IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	GL
01/02/24	IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference	AQ
01/02/24	IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference	GL
03/01/24	IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference	GL
05/12/23	IGM Biosciences Announces Strategic Pipeline Prioritization and Cash Runway Extension	GL
01/12/23	Bulletin from Extraordinary General Meeting in Medivir AB (publ)	PR